Record-Breaking Price Movement
On 22 April 2026, Asarfi Hospital Ltd’s stock price surged by 2.71% to close at ₹231.00, setting a fresh all-time high. This price level is 4.52% above the previous 52-week high of ₹221.00, underscoring the stock’s upward trajectory. The stock has been on a consistent rise, gaining for four consecutive days and delivering a cumulative return of 6.86% during this period. Despite underperforming its sector marginally by 0.25% on the day, Asarfi Hospital outpaced the broader Sensex, which declined by 0.85%.
Strong Relative Performance Over Multiple Timeframes
Asarfi Hospital Ltd has demonstrated remarkable outperformance relative to the market benchmark across various time horizons. Over the past year, the stock has generated a return of 152.40%, vastly exceeding the Sensex’s decline of 1.25% during the same period. Year-to-date, the stock has appreciated by 22.81%, while the Sensex has fallen by 7.77%. The one-month return of 43.52% and three-month return of 35.92% further highlight the stock’s strong momentum compared to the Sensex’s modest gains and losses respectively.
Technical Indicators Confirm Bullish Trend
The technical outlook for Asarfi Hospital Ltd remains bullish, with the stock trading above all key moving averages including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. The overall technical trend shifted to bullish on 13 April 2026 at a price of ₹214.85, signalling a strengthening upward momentum. Key technical indicators such as MACD, Bollinger Bands, KST, and Dow Theory are aligned in a bullish stance on the weekly timeframe, while monthly indicators show a mixed but predominantly positive picture. Immediate support is established at the 52-week low of ₹72.90, with resistance levels previously encountered at the 20-day and 100-day moving averages now surpassed.
Financial Performance Underpinning the Rally
The stock’s ascent to an all-time high is underpinned by a series of strong financial results. The company reported outstanding quarterly results for the period ending December 2025, with net sales reaching a record ₹46.10 crores and profit after tax (PAT) rising sharply by 59.5% to ₹5.42 crores compared to the previous four-quarter average. Return on Capital Employed (ROCE) for the half-year stood at an impressive 18.55%, reflecting efficient utilisation of capital. The company’s net profit growth of 29.05% further reinforces its solid earnings momentum.
Valuation and Quality Metrics
Asarfi Hospital Ltd currently trades at a price-to-earnings (P/E) ratio of 27x and a price-to-book value (P/BV) of 4.72x. The enterprise value to EBITDA multiple stands at 15.46x, while the EV to capital employed ratio is a moderate 3.66x, indicating an attractive valuation relative to the company’s capital base. The PEG ratio is notably low at 0.17x, reflecting the company’s strong earnings growth relative to its valuation.
The company maintains a low debt profile with a Debt to EBITDA ratio of 1.96 times, supporting its ability to service debt comfortably. Capital structure is rated as good, with low leverage and no promoter share pledging. Quality assessments classify the company as average overall, with healthy long-term sales growth at a compound annual growth rate (CAGR) of 22.70% over five years, although operating profit growth has been more moderate at 14.76% annually.
Market Capitalisation and Shareholding
Asarfi Hospital Ltd is classified as a micro-cap company, with promoters holding the majority stake. Institutional holdings remain low at 1.98%, and there is no pledging of promoter shares, which supports shareholder confidence in the company’s governance and financial stability.
Delivery Volumes and Trading Activity
Recent trading activity shows a healthy increase in delivery volumes, with a 1-month delivery change of 39.22% and a 1-day delivery change of 14.47% compared to the 5-day average. On 21 April 2026, delivery volume accounted for 60.47% of total volume, indicating strong investor participation in the stock’s recent price movements.
Summary of Key Financial and Market Metrics
Over the last year, Asarfi Hospital Ltd’s stock has delivered a market-beating return of 152.40%, significantly outperforming the BSE500 index return of 3.69%. The company’s net profit growth of 161% over the same period highlights the strong earnings trajectory supporting the stock price appreciation. The company’s ability to maintain positive results for three consecutive quarters and its highest quarterly earnings per share (EPS) of ₹2.75 further demonstrate operational strength.
Despite the strong recent performance, the company’s long-term operating profit growth remains moderate, with a five-year annual growth rate of 14.76%. This suggests a steady but measured expansion in profitability over the medium term.
Conclusion
Asarfi Hospital Ltd’s stock reaching an all-time high on 22 April 2026 marks a significant achievement reflecting the company’s robust financial health, consistent earnings growth, and positive market sentiment. Supported by strong quarterly results, favourable valuation metrics, and a bullish technical trend, the stock’s performance over the past year has been exceptional relative to broader market indices. While the company’s long-term profit growth is moderate, the recent surge in share price and sustained positive momentum underscore the strength of its current business fundamentals.
